Table 2.
Sociodemographic, immunological and virological profile of chronically HIV-1 infected patients from Northwest Ethiopia
|
Variables |
Male no. (%) |
Female no. (%) |
Total no. (%) |
|---|---|---|---|
| 73 (45.4) | 87 (54.1) | 160 (100.0) | |
| Age (years) |
|
|
|
| <20 |
1 (1.4) |
2 (2.3) |
3 (1.9) |
| 20–29 |
19 (26.0) |
45 (51.7) |
64 (40.0) |
| 30–39 |
33 (45.2) |
24 (27.6) |
57 (35.6) |
| 40–49 |
15 (20.6) |
12 (13.8) |
27 (16.9) |
| ≥50 |
5 (6.8) |
4 (4.6) |
9 (5.6) |
| WHO clinical status |
|
|
|
| I |
6 (8.2) |
13 (14.9) |
19 (11.9) |
| II |
13 (17.8) |
15 (17.2) |
28 (17.5) |
| III |
49 (67.1) |
57 (65.5) |
106 (66.3) |
| IV |
5 (6.8) |
2 (2.3) |
7 (4.4) |
| CD4+ T cell count (cells/mm3) |
|
|
|
| <100 |
26 (35.6) |
26 (29.9) |
52 (32.5) |
| 100–200 |
16 (21.9) |
31 (35.6) |
47 (29.4) |
| 201–350 |
29 (39.7) |
29 (33.3) |
58 (36.3) |
| >350 |
2 (2.7) |
1 (1.1) |
3 (1.9) |
| HIV RNA level (copies/ml) |
|
|
|
| 103–104 |
13 (17.8) |
16 (18.4) |
29 (18.1) |
| 104–105 |
28 (38.4) |
38 (43.7) |
66 (41.3) |
| 105–106 |
29 (39.7) |
28 (32.2) |
57 (35.6) |
| >106 | 3 (4.1) | 5 (5.7) | 8 (5.0) |